Sonic hedgehog and FGF8: Inadequate signals for the differentiation of a dopamine phenotype in mouse and human neurons in culture

被引:31
作者
Stull, ND [1 ]
Iacovitti, L [1 ]
机构
[1] Thomas Jefferson Univ, Coll Med, Dept Neurol, Philadelphia, PA 19107 USA
关键词
dopamine; differentiation; tyrosine hydroxylase; sonic hedgehog; fibroblast growth factor; Parkinson's disease; tissue culture; stem cells; NT2; cells; striatum;
D O I
10.1006/exnr.2001.7640
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Embryonic mouse striatal neurons and human neurons derived from the NT2/hNT stem cell line can be induced, in culture, to express the dopaminergic (DA) biosynthetic enzyme tyrosine hydroxylase (TH). The novel expression of TH in these cells is signaled by the synergistic interaction of factors present in the media, such as fibroblast growth factor 1 (FGF1) and one of several possible coactivators [DA, phorbol 12-myris-tate 13-acetate (TPA), isobutylmethylxanthine (IBMX), or forskolin]. Similarly, in vivo it has recently been reported that the expression of TH in the developing midbrain is mediated by the synergy of FGF8 and the patterning molecule sonic hedgehog (Shh). In the present study, we examined whether the putative in vivo DA differentiation factors can similarly signal TH in our in vitro cell systems. We found that FGF8 and Shh induced TH expression in fewer than 2% of NT2/ hNT cells and less than 5% of striatal neurons. The latter could be amplified to as much as 30% by increasing the concentration of growth factor 10-fold or by the addition of other competent coactivators (IBMX/ forskolin, TPA, and DA). Additivity/inhibitor experiments indicated that FGF8 worked through traditional tyrosine kinase-initiated MAP/MEK signaling pathways. However, the Shh signal transduction cascade remained unclear. These data suggest that cues effective in vivo may be less successful in promoting the differentiation of a DA phenotype in mouse and human neurons in culture. Thus, our ability to generate DA neurons from different cell lines, for use in the treatment of Parkinson's disease, will depend on the identification of appropriate differentiation signals for each cell type under investigation. (C) 2001 Academic Press.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 39 条
[1]   BRAIN-DERIVED NEUROTROPHIC FACTOR WORKS COORDINATELY WITH PARTNER MOLECULES TO INITIATE TYROSINE-HYDROXYLASE EXPRESSION IN STRIATAL NEURONS [J].
DU, XY ;
STULL, ND ;
IACOVITTI, L .
BRAIN RESEARCH, 1995, 680 (1-2) :229-233
[2]   Multiple signaling pathways direct the initiation of tyrosine hydroxylase gene expression in cultured brain neurons [J].
Du, XY ;
Iacovitti, L .
MOLECULAR BRAIN RESEARCH, 1997, 50 (1-2) :1-8
[3]  
DU XY, 1995, J NEUROSCI, V15, P5420
[4]  
Du XY, 1997, J NEUROCHEM, V68, P564
[5]  
DU XY, 1994, J NEUROSCI, V14, P7688
[6]   Prospects for new restorative and neuroprotective treatments in Parkinson's disease [J].
Dunnett, SB ;
Björklund, A .
NATURE, 1999, 399 (6738) :A32-A39
[7]  
Epstein DJ, 1996, DEVELOPMENT, V122, P2885
[8]   Mammalian neural stem cells [J].
Gage, FH .
SCIENCE, 2000, 287 (5457) :1433-1438
[9]  
Guo Z, 1998, J NEUROSCI, V18, P8163
[10]   Protein kinase A is a common negative regulator of Hedgehog signaling in the vertebrate embryo [J].
Hammerschmidt, M ;
Bitgood, MJ ;
McMahon, AP .
GENES & DEVELOPMENT, 1996, 10 (06) :647-658